BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24670043)

  • 1. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.
    Basso D; Bozzato D; Padoan A; Moz S; Zambon CF; Fogar P; Greco E; Scorzeto M; Simonato F; Navaglia F; Fassan M; Pelloso M; Dupont S; Pedrazzoli S; Fassina A; Plebani M
    Cell Commun Signal; 2014 Mar; 12():20. PubMed ID: 24670043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells.
    Moz S; Basso D; Bozzato D; Galozzi P; Navaglia F; Negm OH; Arrigoni G; Zambon CF; Padoan A; Tighe P; Todd I; Franchin C; Pedrazzoli S; Punzi L; Plebani M
    Oncotarget; 2016 Oct; 7(43):69927-69944. PubMed ID: 27655713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
    Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
    Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
    Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
    BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8).
    Basso D; Greco E; Padoan A; Fogar P; Scorzeto M; Fadi E; Bozzato D; Moz S; Navaglia F; Zambon CF; Seraglia R; De Carlo E; Valerio A; Reggiani C; Pedrazzoli S; Plebani M
    J Cell Physiol; 2011 Feb; 226(2):456-68. PubMed ID: 20717964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells.
    Sheikh AA; Vimalachandran D; Thompson CC; Jenkins RE; Nedjadi T; Shekouh A; Campbell F; Dodson A; Prime W; Crnogorac-Jurcevic T; Lemoine NR; Costello E
    Proteomics; 2007 Jun; 7(11):1929-40. PubMed ID: 17469085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.
    Xu Z; Cheng C; Kong R; Liu Y; Wang S; Ma Y; Xing X
    Aging (Albany NY); 2021 Jun; 13(11):15523-15537. PubMed ID: 34099591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway.
    Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B
    Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia.
    Mitrović Ajtić O; Subotički T; Diklić M; Đikić D; Vukotić M; Dragojević T; Živković E; Antić D; Čokić V
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
    Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
    Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
    Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
    Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
    Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
    Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
    Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
    Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers.
    Riva M; He Z; Källberg E; Ivars F; Leanderson T
    PLoS One; 2013; 8(4):e61832. PubMed ID: 23626736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/A9 induces microglia activation and promotes the apoptosis of oligodendrocyte precursor cells by activating the NF-κB signaling pathway.
    Wu M; Xu L; Wang Y; Zhou N; Zhen F; Zhang Y; Qu X; Fan H; Liu S; Chen Y; Yao R
    Brain Res Bull; 2018 Oct; 143():234-245. PubMed ID: 30266587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
    Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
    BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.